hotspot -WSS

hotspot

author：comprehensive 2025-09-03 07:51:41 - browse：96122

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024.

Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023. Humana also is “currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue,” according to the company’s update to investors.

Humana’s bad news for Wall Street didn’t end there: The company said it appears it only added just 100,000 new Medicare Advantage members from the most recent enrollment period that ended last month — down from estimates that it would enroll anywhere from 325,000 to 435,000 people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Kale crackers and hibiscus tea: My five days on a 'fasting diet'

entertainment

WSS

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

RaDonda Vaught to speak at CommonSpirit event on patient safety

RSV vaccines may be linked to small increased risk of developing GBS

Kenai launches with $82 million for Parkinson’s stem cell therapy

CDC director unscathed in first congressional testimony

Why getting cancer drugs just got harder for rural patients

entertainment

hotspot

knowledge

Heart attack and stroke risk calculators need revising

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

State Dept. review finds Biden bears some blame for Afghanistan failures

U.K. Biobank has 500,000 peoples' genome sequences available

Jerome Adams on the need for new antivirals for Covid

FDA investigates CAR

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA investigates CAR

Virginia high school admissions case could be legal follow

Fetal surgery at risk from Dobbs and new abortion restrictions

leisure time

CDC director unscathed in first congressional testimony

30 years of 'Listening to Prozac'

In search for therapies for solid tumors, companies turn to claudin

Kenai launches with $82 million for Parkinson’s stem cell therapy

Covid isolation guidance eased by the CDC

Takeda, Janssen join wearable maker to measure scratching

knowledge

entertainment

hotspot

leisure time